Global Medical Inhaled Nitric Oxide Market Growth Projection: Aiming for USD 1,520 Million by 2030 with a 7.7% CAGR
September 18, 2023 07:24 ET
|
Zion Market Research
Washington, DC, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “Medical Inhaled Nitric Oxide Market By Product Type (Inhaled Nitric Oxide Delivery...
Cardiotonic Agents Market Size to Reach USD 4.5 Bn by 2031 Due to the Rise in Prevalence of Cardiovascular Diseases | TMR Study
April 03, 2023 11:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, April 03, 2023 (GLOBE NEWSWIRE) -- According to the market study by Transparency Market Research, the global cardiotonic agents market was worth USD 732 Million...
Inhaled Nitric Oxide Market Size is projected to reach USD 1.54 Billion by 2030, growing at a CAGR of 8.4%: Straits Research
August 11, 2022 16:00 ET
|
Straits Research
New York, United States, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Inhaled nitric oxide is a pulmonary vasodilator that considerably controls vascular muscle tone. It has emerged as a therapy for hypoxemic...
Pulmonary Hypertension Clinical Trials Pipeline Offers Promising Novel Treatment Options | DelveInsight
August 01, 2022 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Pulmonary Hypertension Clinical Trials Pipeline Offers Promising Novel Treatment Options | DelveInsight DelveInsight’s pulmonary hypertension...
Ferrer Announces Distribution Agreement With United Therapeutics for Treprostinil Inhalation Solution for Pulmonary Hypertension Associated With Interstitial Lung Disease
February 28, 2022 06:00 ET
|
Ferrer
BARCELONA, Spain, Feb. 28, 2022 (GLOBE NEWSWIRE) -- In the run up to Rare Disease Day, which is held on 28 February, International pharmaceutical company Ferrer has strengthened its focus on...
Halo Biosciences Participating in BIO @ JPM and BIOTECH SHOWCASE™ During J.P. Morgan Week 2022
January 10, 2022 08:00 ET
|
Halo Biosciences
SAN FRANCISCO, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Halo Biosciences, a clinical stage biopharmaceutical company today announced that its Chief Executive Officer, Anissa Kalinowski, MSc, MBA, will...
Nu-Med Plus Closely Monitoring Outcomes on Two New Human Clinical Trials Using Inhaled Nitric Oxide in Treatment of COVID-19
March 25, 2020 06:00 ET
|
Nu-Med Plus Inc.
SALT LAKE CITY, March 25, 2020 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), a medical device company which investigates and develops applications and devices for nitric oxide in the medical...
38th Annual International Society for Heart and Lung Transplantation (ISHLT) Annual Meeting & Scientific Sessions Kicks Off with the INTERHEART Study, Pulmonary Hypertension and Heart Attack Recovery Using LVADs
April 11, 2018 06:50 ET
|
International Society for Heart & Lung Transplantation
NICE, France, April 11, 2018 (GLOBE NEWSWIRE) -- Researchers at the Alberta Transplant Applied Genomics Centre (ATAGC) at the University of Alberta in Edmonton, Canada presented results of The...
GREAT DEBATES IN PULMONARY HYPERTENSION AT THE 37th ANNUAL ISHLT MEETING AND SCIENTIFIC SESSIONS
April 07, 2017 16:35 ET
|
International Society for Heart & Lung Transplantation
San Diego, April 07, 2017 (GLOBE NEWSWIRE) -- Today at the 37th Annual International Society for Heart and Lung Transplantation (ISHLT) Meeting & Scientific Sessions, researchers and physicians...
University of Colorado Hospital Announces new Center for Lungs and Breathing
October 01, 2015 09:05 ET
|
UCHealth
AURORA, COLO., Oct. 1, 2015 (GLOBE NEWSWIRE) -- UCHealth's University of Colorado Hospital (UCH), a national leader in pulmonology, cancer and upper airway disorders, opens its new multidisciplinary...